Treatment-Resistant Depression and how is it best treated?

Treatment-Resistant Depression and how is it best treated?

If you’ve been diagnosed with Depression but your symptoms aren’t improving, you may have Treatment-Resistant Depression (TRD). Though therapy and antidepressants work for the majority of people, TRD does not improve with standard treatments. How do you know if you suffer from TRD?

Below are common symptoms that you may be experiencing.

TRD is a descriptive category and not a diagnosis. There can be many causes of TRD and can range from high-stress levels to specific physical health conditions.

Common causes of TRD might be:

If these TRD symptoms feel familiar, SPRAVATO® might be an alternative treatment, that is used in conjunction with standard treatment, can prove successful for treating TRD. What is  SPRAVATO™? It’s a nasal spray that targets the N-methyl-D (NMDA) receptor and is believed to work differently to treat depression than other oral antidepressants. If you or a family member suffer from Treatment-Resistant Depression (TRD) and you are looking for an alternative or addition to your current treatment plan, consider SPRAVATO™ through Compassionate Psychiatric Services (CPS).

 Call today to find out how this innovative therapy might be right for you.

You Might Also Enjoy...

SPRAVATO® – The First of its Kind

SPRAVATO™ nasal spray is a different kind of medication taken with an oral antidepressant for adults with treatment-resistant depression – a first in decades approved by the FDA. Treatment-resistant depression is a complex...

Treatment-Resistant Depression

Imagine being depressed and trying medication after medication—only to find none work. That’s the plight of people with treatment-resistant depression.

What is TMS Therapy?

Transcranial magnetic stimulation (TMS) targets key areas of the brain that are underactive in people with depression. It is not ECT (electroconvulsive therapy).

What is Spravato?

SPRAVATO™ nasal spray is a different kind of medication taken with an oral antidepressant for adults with treatment-resistant depression – a first in decades approved by the FDA.